Effect of homoeopathic medicines for managing bedwetting in children

A double-blind, randomized, placebo-controlled trial of individualized homoeopathic medicines in the treatment of paediatric enuresis - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/07/113819

Enrollment

159

Registered

2026-07-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F980- Enuresis not due to a substance orknown physiological condition

Interventions

Intervention1: Individualized homeopathic medicines in individualized dosage plus concomitant care: Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies (C

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing their teeth w

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of age group 5 to 18 yrs 2. Patient suffering from enuresis ICD11- 6C00.0 with bedwetting episodes more than equals to 2 times per week for at least 3 consecutive months. 3. Participants of either sex or transgender.

Exclusion criteria

Exclusion criteria: 1. Denying informed concent. 2. Patient having any congenital anomalies leading to enuresis. 3. Secondary paediatric enuresis. 4. Patients who have taken any systemic antibiotics in the past one month. 5. Urinary tract infection confirmed by urine routine and microscopic examination and KUB ultrasonography if known case of UTI, and worm infestation confirmed by stool ova, parasite and cyst. 6. Tobacco chewing and or smoking, alcoholism and or any forms of substance abuse. 7. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life threatening illness affecting quality of life or any organ failure. 8. Self reported immunocompromised status, or patients too ill to participate in consultation or study. 9. Undergoing homoeopathic treatment for any chronic disease within the last 6 months 10. Simultaneous participation in any other clinical trials.

Design outcomes

Primary

Measure	Time frame
Frequency of bedwetting eventsTimepoint: Baseline, and every month, up to 3 months	—

Secondary

Measure	Time frame
Nocturnal enuresis severity scale questionnaire NESSTimepoint: Baseline, and every month, up to 3 months;Dysfunctional voiding symptom score questionnaire DVSSTimepoint: Baseline, and every month, up to 3 months	—

Countries

India

Contacts

Public ContactPallab Haldar

D N De Homoeopathic Medical College and Hospital

drvpbharti@gmail.com9231692840

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026